On-Demand Content | Virtual Event

AGENDA – ALL TIMES ARE IN EASTERN TIME

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE
For centuries women have been making significant strides in the pharmaceutical industry to increase the amount of female leaders that hold high positions of power. With this being said, it is important for women leaders to be courageous and focus on enterprise and innovation. Women leaders are advancing on how they are managing their business with ensuring they have the necessary exposure to grow by reflecting market needs and changing the culture around them. What helps you sleep better at night? Doing the right thing - or going above and beyond what you were told? In this keynote, you will learn how to successfully build this way of thinking - don't be afraid to be bold and innovative, it may be more important to fail at trying something new that succeeding at something you're used to.

Moderator:
Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE

Panelists:
Deborah Dunsire, M.D.
Chief Executive Officer
LUNDBECK

Kellie Malloy Foerter
Vice President, Global Clinical Trial Strategy & Operations (GCTS&O) for Late Development
BRISTOL MYERS SQUIBB 

Kinnari Patel, PharmD, MBA
President, Chief Operating Officer
ROCKET PHARMACEUTICALS

Tamara Lovi, MBA
Pharma Commercial Leader, Co-Founder
WOMEN LEADERS IN PHARMA
Panelists will discuss how they are creating a culture of breakthrough thinking and innovation and high-performance teams during myriad and unprecedented challenges. Today, more than ever, this requires new ways of thinking, resiliency, flexibility, empathy, and tapping into new leadership skills and techniques.

Moderator:
Ravi Kiron
Head, BioPharma External Innovation
EMD SERONO

Panelists:
Al Altomari,
Chairman and Chief Executive Officer,
AGILE THERAPEUTICS 

Joanne Quan
Chief Medical Officer
ZOGENIX

Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!



Meet The Speaker Roundtable For The 10:05 Session

Kellie Malloy Foerter
Vice President, Global Clinical Trial Strategy & Operations (GCTS&O) for Late Development
BRISTOL MYERS SQUIBB

Kinnari Patel, PharmD, MBA
President, Chief Operating Officer
ROCKET PHARMACEUTICALS

Deborah Dunsire, M.D.
Chief Executive Officer
LUNDBECK

Tamara Lovi, MBA
Pharma Commercial Leader, Co-Founder
WOMEN LEADERS IN PHARMA
Meet The Speaker Roundtable For The 10:40 Session

Cameron Durrant, M.D.
Chairman and Chief Executive Officer
HUMANIGEN
Meet The Speaker Roundtable For The 11:05 Session

Ravi Kiron
Head, BioPharma External Innovation
EMD SERONO

Joanne Quan
Chief Medical Officer
ZOGENIX

Al Altomari,
Chairman and Chief Executive Officer
AGILE THERAPEUTICS
Women's health has been vastly ignored for many years, despite women making the majority of the healthcare decisions in the family and controlling the family dollar. It is imperative for innovative companies to understand how women perceive solutions to their healthcare problems while overcoming significant barriers preventing companies from being successful in the women's health field. Success depends on convenience of the solution, improved outcomes, procedure safety, cost, reimbursement, physician economics, investment, and successful exits.

Bill Gruber
President and Chief Executive Officer
SOLACE THERAPEUTICS 

Andrea S. Lukes, MD, MHSc, FACOG
Chief Medical Officer
HEALTH DECISIONS
  • Building a foundational communications platform to focus on the landscape of women and their health
  • Drive and implement a strategic communications plan to successfully create a commercial campaign for your target audience
  • Understand how companies are adapting to this changing environment
Wendy Lund
Chief Communications Officer
ORGANON & CO.
Taking the lead to become an entrepreneur is not for the faint of heart; it takes guts, determination, and a clear vision. Panelists will discuss the ins and outs and the ups and downs of carving out a new space in the life-sciences ecosystem.

Moderator:
Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE

Panelists:
Troy Wilson
President, Chief Executive Officer, and Founder
KURA ONCOLOGY

Paula Ragan,
President, Chief Executive Officer
X4 PHARMACEUTICALS

Ryan Saadi, M.D., M.P.H
Chief Executive Officer, Founder
TEVOGEN BIO
Patient centricity isn’t just a marketing term designed to soften pharma’s image. When sponsors introduce the patient voice into trial decision-making, they can finally transition from developing drugs for patients to developing drugs with patients. That change can make every step of the clinical research journey faster, easier, and more productive.

Katie Shaw
Senior Director, Patient Recruitment and Enablement
IQVIA

A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!



Meet The Speaker Roundtable For The 12:00 Session

Bill Gruber
President and Chief Executive Officer
SOLACE THERAPEUTICS

Andrea S. Lukes, MD, MHSc, FACOG
Chief Medical Officer
HEALTH DECISIONS
Meet The Speakers Roundtable For The 12:25 Session

Wendy Lund
Chief Communications Officer
ORGANON & CO.
Meet The Speaker Roundtable For The 12:50 & 1:15 Session

Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE

Panelists:
Paula Ragan,
President, Chief Executive Officer
X4 PHARMACEUTICALS

Ryan Saadi, M.D., M.P.H
Chief Executive Officer, Founder
TEVOGEN BIO

Katie Shaw
Senior Director, Patient Recruitment and Enablement
IQVIA
  • Understand the development of a drug in an international organization or geographic
  • Understand the process of working with other biotech/companies to develop a drug
  • Deliberately working with a company to ensure your drug is affordable upfront for the patient and fulfill your organization's commitment
Pol Vandenbroucke
Chief Medical Officer
PFIZER 
  • Understand the framework used by companies in their approach to DE&I both internally and externally
  • Strategies for developing and sustaining DE&I initiatives across your companies and with your leadership
  • Explore goals and metrics to assess progress and make improvements
  • Discuss the strategies and tactics being deployed to increase diversity in clinical trials in the Life Science industry
Moderator:
Nicole Platzer
Head of External Diversity, Inclusion and Belonging
ALEXION PHARMACEUTICALS

Panelists: 
Sara Nochur
Chief Diversity, Equity and Inclusion Officer
ALNYLAM PHARMACEUTICALS

Janine Jansen
Senior Director, Diversity and Inclusion
TEVA PHARMACEUTICALS

Susan Manoff
Executive Director, Vaccines and Infectious Diseases | Office of the Chief Patient Officer
MERCK

Alicia Staley
Vice President of Patient Engagement
MEDIDATA, A DASSAULT SYSTEMES COMPANY

Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!



Meet The Speaker Roundtable for 2:15 Session

Pol Vandenbroucke
Chief Medical Officer
PFIZER
Meet The Speaker Roundtable for 2:40 Session

Sara Nochur
Chief Diversity, Equity and Inclusion Officer
ALNYLAM PHARMACEUTICALS

Janine Jansen
Senior Director, Diversity and Inclusion
TEVA PHARMACEUTICALS

Susan Manoff
Executive Director, Vaccines and Infectious Diseases | Office of the Chief Patient Officer
MERCK

Nicole Platzer
Head of External Diversity, Inclusion and Belonging
ALEXION PHARMACEUTICALS

Alicia Staley
Vice President of Patient Engagement
MEDIDATA, A DASSAULT SYSTÈMES COMPANY

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

At Merck, when we embark on the development of a commercial manufacturing process for a promising drug candidate, we strive to design the most direct method to convert commodity chemicals into the target molecule with zero waste.  Inevitably, the transformations that we imagine do not exist, and we foster a mentality that thinks creatively and purposefully invents novel synthetic methods to achieve this aspirational goal.  Through investment in this mindset of innovation, Merck has established a legacy of breathtaking, yet practical, solutions to vexing synthetic issues, providing countless benefits to how our medicines are manufactured,  maximizing access to our medicines for patients worldwide, and influencing the field of synthetic chemistry as we do it.  How our strategy is realized through investments in talent, technology, and culture will be discussed.

Kevin Campos 
Assistant Vice President, Head of Small Molecule Process Research and Development 
MERCK
In this keynote, Dr. Anthony Yanni will explore Astellas’ breakthrough operating model for patient focused medicine development and delivery, disrupting the industry’s status quo to drive impact for patients and value for the organization. Drawing on past experiences in both the clinic and industry, he’ll explore the courageous thinking that challenged the traditional pharma drug discovery, development and delivery approach and led to the creation of a global patient centricity division within Astellas that’s infusing the patient perspective into every decision, in every division, every day.

Dr. Anthony Yanni
Senior Vice President, Patient Centricity
ASTELLAS
In this keynote session, Saundra Pelletier will share how she launched Phexxi® (lactic acid, citric acid and potassium bitartrate), an innovative, non-hormonal, on-demand birth control to meet a significant unmet need for millions of women. She will also discuss the challenges and successes in bringing a first-in-class product to market.

Saundra Pelletier
President, Chief Executive Officer
EVOFEM BIOSCIENCES
Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

Meet The Speaker Roundtable for 10:00 Session

Kevin Campos
Assistant Vice President, Head of Small Molecule Process Research and Development
MERCK
Meet The Speaker Roundtable for 10:25 Session

Dr. Anthony Yanni
Senior Vice President, Patient Centricity
ASTELLAS
Meet The Speaker Roundtable for 10:45 Session

Saundra Pelletier
President, Chief Executive Officer
EVOFEM BIOSCIENCES
Steffen Kurzawa
Global Head of Communications and Engagement
SANDOZ
  • Adopting clinical trial designs with HEOR to convey a medicine’s value story
  • Importance of applying DE&I across the industry in the early development phase for clinical trials
  • Using a patient centric approach and further innovation to solve unmet needs for patients
Moderator:
Synim Rivers
Director, Communications - Research & Development
HORIZON THERAPEUTICS

Panelists:
Dr Yele Aluko M.D., MBA
Chief Medical Officer
EY AMERICAS

Chazeman S. Jackson, PhD, MA
Health Science Researcher & Equity Advocate
COBB SCHOLAR, W. MONTAGUE COBB/NMA HEALTH INSTITUTE

Lauren R. Powell, MPA, PhD
Vice President, US Medical Health Equity and Community
TAKEDA PHARMACEUTICALS

Stephanie Taylor, PhD
Director, Health Economics and Outcomes Research, Medical Affairs
HORIZON THERAPEUTICS
Panelists will discuss their approach to creating a culture of innovation that leads to breakthrough drug discovery, development, and eventual commercialization of new therapies.

Moderator:
Brinda Balakrishnan, Ph.D., M.D. ,
Group Vice President, Corporate and Business Development
BIOMARIN PHARMACEUTICALS

Panelists:
Mike Rea,
Chief Executive Officer and Founder,
IDEA PHARMA

Bert Hartog, Ph.D. ,
Senior Director, Research and Development Operations
JANSSEN

Craig Serra,
Clinical Technology and Innovation
NOVARTIS

Vicky Leamy, MPH
Vice President, Internal Medicine
IQVIA
Keynote Plenary Presentation: Addressing Unmet Medical Needs Through Bold Innovation

Today’s mainstay treatments are yesterday’s innovations. To extend and improve patients’ lives, we have a duty, a responsibility, and a desire to transform standards of care and create the innovations of tomorrow. Developing and delivering transformative innovations to those in need requires a combination of many elements.

Susanne can share her perspectives on the ‘ingredients for innovation’, and how, as a scientist and leader of 20+ years at Novartis, she is using her power for purpose to harness 10,000 people with a shared mission to cure cancer. She believes creating a culture of innovation is paramount—a culture that is purposeful, courageous, and curious. Developing transformative innovations, however, is one thing, but ensuring that where people live doesn’t determine their ability to access them, is another. Susanne can talk about those challenges, and how it takes collaboration, creativity, and a why not attitude to overcome them.

Susanne Schaeffert, Ph.D.
President
NOVARTIS ONCOLOGY

1:30 PM EST - 1:50 PM EST

Oncology Spotlight Fireside Chat:

Susanne Schaffert
President,
NOVARTIS ONCOLOGY

Ellen Cappellino
Senior Vice President, Market Access and Patient Services
EVERSANA™ COMPLETE COMMERCIALIZATION

Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE
Meet The Speaker Roundtable for 11:25 & 11:45 Session

Steffan Kurzawa
Global Head of Communications and Engagement
SANDOZ

Synim Rivers
Director, Communications - Research & Development
HORIZON THERAPEUTICS

Chazeman S. Jackson, PhD, MA
Health Science Researcher & Equity Advocate
COBB SCHOLAR, W. MONTAGUE COBB/NMA HEALTH INSTITUTE

Lauren R. Powell, MPA, PhD
Vice President, US Medical Health Equity and Community
TAKEDA PHARMACEUTICALS

Stephanie Taylor, PhD
Director, Health Economics and Outcomes Research, Medical Affairs
HORIZON THERAPEUTICS

Dr Yele Aluko M.D., MBA
Chief Medical Officer
EY AMERICAS
Meet The Speaker Roundtable for 12:25 Session

Brinda Balakrishnan, Ph.D., M.D,
Group Vice President, Corporate and Business Development
BIOMARIN PHARMACEUTICALS

Vicky Leamy, MPH
Vice President, Internal Medicine
IQVIA

Mike Rea
Chief Executive Officer and Founder
IDEA PHARMA

Bert Hartog, Ph.D.
Senior Director, Research and Development Operations
JANSSEN

Craig Serra
Global Head, Innovation Data Operations
NOVARTIS
Meet The Speaker Roundtable for 1:10 & 1:30 Session

Susanne Schaeffert, Ph.D.
President
NOVARTIS ONCOLOGY

Ellen Cappellino
Senior Vice President, Market Access and Patient Services
EVERSANA™ COMPLETE COMMERCIALIZATION
Commercialization takes comprehensive thinking, measured approaches and resilient innovators to move product adoption forward. Breakthrough strategies are required for products to benefit patients and secure their position in the market. Building and retaining relationships with those patients and providers is even more essential in today’s world.

Shetal Vyas, MBA
Vice President, Head of Operations
FERRING PHARMACEUTICALS
  • Hear how medical affairs capabilities are evolving to support the new era of data-driven medicine
  • Review actionable and innovative tactics to enhance the value proposition of medical affairs
  • Learn how to leverage AI to synthesize insights and measure the impact of engagements with healthcare providers
Andrew Rosen, PhD
Director of Global Data Generation
IONIS PHARMACEUTICALS
  • Discuss why an omnichannel approach is imperative to reach patients, caregivers, physicians, and other stakeholders
  • Utilizing meaningful messages by using innovative targeting and engagement strategies
Moderator:
Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE

Panelists:
Michael Rowbotham
Director, Multi-Channel Marketing
PFIZER

Lisa Flaiz
Director, Multi-Channel Marketing, WW Digital Hub Lead
BRISTOL MYERS SQUIBB

Kevin Yapp
Global Head, Omni-Channel Transformation
ALCON
Meet The Speaker Roundtable for 2:20 Session

Shetal Vyas, MBA
Vice President, Head of Operations
FERRING PHARMACEUTICALS
Meet The Speaker Roundtable for 2:45 & 3:15 Session

Andrew Rosen, PhD
Director of Global Data Generation
IONIS PHARMACEUTICALS

Michael Rowbotham
Director, Multi-Channel Marketing
PFIZER

Lisa Flaiz
Director, Multi-Channel Marketing, WW Digital Hub Lead
BRISTOL MYERS SQUIBB

Kevin Yapp
Global Head, Omni-Channel Transformation
ALCON
Taren Grom
Co Founding Partner, Editor in Chief
PHARMAVOICE